Thursday, January 19, 2023 Daily Archives

Pfizer to acquire Abzena’s NC manufacturing plant

by

Pfizer is set to acquire a drug substance facility in Sanford, North Carolina from Abzena to expand capacity and support its CentreOne clients. British contract development manufacturing organization (CDMO) Abzena announced the addition of a sixth global site in the US in January 2021. Three months later, the firm revealed it had selected Sanford, North Carolina as the site of a biologics manufacturing facility, which would cost the firm over $200 million and be equipped with 12x 2,000 L bioreactors.…

January 19, 2023

Aton Bio: China pharma backed CDMO with a startup spirit

by

Aton Biotech hopes to make big waves in the bio-CDMO space by leveraging up to 144,000 L of bioreactor capacity from parent company Shanghai Henlius Biotech. Henlius operates two biomanufacturing in Shanghai with a total of 48,000 L of bioreactor capacity, along with fully integrated drug substance and drug product capabilities. The firm broke ground on a third 130,000 square meter facility last year, the first phase of which will incorporate 36,000 L of biomanufacturing capacity comprising of up to…

January 19, 2023